Given this challenge, our study aimed to rigorously assess the ADCC and anticancer effects of donor‐derived NK cells, using a coculture system of HER2‐positive breast cancer cells and an array of other solid tumor cells. This evidence concerns the gene ERBB2 and breast carcinoma.